Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

A systematic approach to obtain validated partial least square models for predicting lipoprotein subclasses from serum NMR spectra.

Mihaleva VV, van Schalkwijk DB, de Graaf AA, van Duynhoven J, van Dorsten FA, Vervoort J, Smilde A, Westerhuis JA, Jacobs DM.

Anal Chem. 2014 Jan 7;86(1):543-50. doi: 10.1021/ac402571z. Epub 2013 Dec 18.

PMID:
24319989
2.

Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.

Petersen M, Dyrby M, Toubro S, Engelsen SB, Nørgaard L, Pedersen HT, Dyerberg J.

Clin Chem. 2005 Aug;51(8):1457-61. Epub 2005 Jun 16.

3.

Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ; Pittsburgh Epidemiology of Diabetes Complications Study.

Diabetologia. 2003 May;46(5):674-82. Epub 2003 May 13.

PMID:
12743701
4.

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.

Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.

Diabetes. 2003 Feb;52(2):453-62.

5.

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL.

Invest Ophthalmol Vis Sci. 2004 Mar;45(3):910-8.

PMID:
14985310
6.

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

Kelley DS, Siegel D, Vemuri M, Mackey BE.

Am J Clin Nutr. 2007 Aug;86(2):324-33.

7.

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA.

Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1046-53.

8.

Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH.

Diabetes. 2002 Jun;51(6):1949-56.

9.

Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.

Okazaki M, Usui S, Ishigami M, Sakai N, Nakamura T, Matsuzawa Y, Yamashita S.

Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):578-84. Epub 2005 Jan 6.

10.

Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.

Mostad IL, Bjerve KS, Lydersen S, Grill V.

Eur J Clin Nutr. 2008 Mar;62(3):419-29. Epub 2007 Feb 28.

PMID:
17327864
11.

Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.

Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ.

Clin Chem. 2004 Jul;50(7):1189-200. Epub 2004 Apr 23.

12.

Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.

Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.

Clin Exp Hypertens. 2001 Aug;23(6):489-500. Erratum in: Clin Exp Hypertens 2001 Nov;23(8):667.

PMID:
11478431
13.

Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients.

Petersen M, Pedersen H, Major-Pedersen A, Jensen T, Marckmann P.

Diabetes Care. 2002 Oct;25(10):1704-8.

PMID:
12351465
14.

Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis.

Bathen TF, Krane J, Engan T, Bjerve KS, Axelson D.

NMR Biomed. 2000 Aug;13(5):271-88.

PMID:
10960918
15.

Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study.

Choo J, Ueshima H, Curb JD, Shin C, Evans RW, El-Saed A, Kadowaki T, Okamura T, Nakata K, Otake T, Miura K, Abbott RD, Sutton-Tyrrell K, Edmundowicz D, Kuller LH, Sekikawa A; ERA-JUMP Study Group.

Am J Clin Nutr. 2010 May;91(5):1195-203. doi: 10.3945/ajcn.2009.28500. Epub 2010 Mar 31.

16.

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.

Circulation. 2006 Mar 28;113(12):1556-63. Epub 2006 Mar 13.

17.

Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.

Männistö VT, Simonen M, Soininen P, Tiainen M, Kangas AJ, Kaminska D, Venesmaa S, Käkelä P, Kärjä V, Gylling H, Ala-Korpela M, Pihlajamäki J.

J Lipid Res. 2014 Dec;55(12):2676-84. doi: 10.1194/jlr.P054387. Epub 2014 Oct 24. Erratum in: J Lipid Res. 2016 Apr;57(4):743.

18.

Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.

Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA.

Am J Cardiol. 2002 Oct 17;90(8A):71i-76i.

PMID:
12419483
19.

Effects of dietary cholesterol on plasma lipoproteins and their subclasses in IDDM patients.

Romano G, Tilly-Kiesi MK, Patti L, Taskinen MR, Pacioni D, Cassader M, Riccardi G, Rivellese AA.

Diabetologia. 1998 Feb;41(2):193-200.

PMID:
9498653
20.

Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.

Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):744-9. Epub 2004 Jan 29.

Supplemental Content

Support Center